memo - Magazine of European Medical Oncology

Approaching personalized cancer medicine

• Commentary

G. Gastl

CECOG at ASCO 2008

• CECOG News

Dagmar Just

Proteomics, a new tool to monitor cancer therapy?

• Review

J. Loeffler-Ragg, B. Sarg, D. Mueller, T. Auer, H. Lindner, H. Zwierzina

Personalized medicine – p53 gene analysis for prediction of response to neoadjuvant therapy in esophageal cancer

• Short review

D. Kandioler

Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?

• Short review

A. Eniu

Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation

• Case report

K. Prassl, A. Sahanic, B. Reicher, H. Denz, M. Freund, M. Fiegl

Ocular abnormality as the first sign of metastatic breast cancer: the presentation of two cases

• Case report

Z. Kahán, Á. Szabó, A. Cserháti

"Old tricks and new procedures" – a report from the 34th Annual Meeting of the European Group for Blood and Marrow Transplantation EBMT, March 30 – April 2, 2008, Florence, Italy

• Congress report

E. Willenbacher, W. Willenbacher

Targetable oncogenic pathways in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma

• Review

A. Tzankov

Treatment options in localised and metastatic renal cell carcinoma

• Short review

A. P. Berger, A. Hobisch

Individualized molecular cancer therapy based on radiolabelled somatostatin analogues

• Review article

M. Gabriel, U. Andergassen, I. J. Virgolini

Therapeutic options for the treatment of infections with multiresistant grampositive bacteria in oncological patients

• Short review

G. Fritsche, G. Weiss

Announcement

• Announcement